Literature DB >> 3924358

[Regulation of neoplasm-specific cathepsin B by cysteine-protease inhibitors present in cancerous exudates].

D Keppler, M Pagano, V Dalet-Fumeron, R Engler.   

Abstract

The Cathepsin B-like proteinase, a secretory form of lysosomal cathepsin B, is present in some cancerous exudates (i.e. pleural and ascitic fluids). It has been suggested that this enzyme may be involved in the invasive process, one of the most important aspects of cancer pathology. In the same fluids, two kinds of cysteine-proteinase inhibitors (C.P.I.'s) are found- HMr-CPI (90,000 daltons) and LMr-CPI's (11,000-13,000 daltons). The Cathepsin B-like enzyme is more strongly inhibited by the LMr-CPI's than by the HMr-CPI, the Ki values are 4.0 X 10(-9) M and 1.2 X 10(-7) M respectively. Theses results underline the similarity between this enzyme and the lysosomal Cathepsin B. On the other hand, the inhibitors could play a protective role against tumor invasion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924358

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  2 in total

1.  Purification and characterization of a newly serine protease inhibitor from Rhamnus frangula with potential for use as therapeutic drug.

Authors:  Abir Ben Bacha; Ikram Jemel; Nadine M S Moubayed; Imen Ben Abdelmalek
Journal:  3 Biotech       Date:  2017-06-08       Impact factor: 2.406

2.  Protease inhibitor from Moringa oleifera with potential for use as therapeutic drug and as seafood preservative.

Authors:  B Bijina; Sreeja Chellappan; Jissa G Krishna; Soorej M Basheer; K K Elyas; Ali H Bahkali; M Chandrasekaran
Journal:  Saudi J Biol Sci       Date:  2011-04-18       Impact factor: 4.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.